BLTE Q4 2021 Earnings — Belite Bio, Inc Revenue & Financial Results | Market Cap Arena

BLTEBelite Bio, Inc

$7B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-0.26

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$1,994

Free Cash Flow

-$20,494

Stock-Based Comp.

-$444

Balance Sheet

Total Assets

$18M

Total Liabilities

$33M

Stockholders' Equity

-$15M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$2M	-$2M	-37.6%
Net Income	-$2M	-$2M	-35.8%